These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 18316103

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Logistics and models of implementing large-scale HIV treatment, care and support in Africa.
    Darkoh-Ampem E, Sargent J, Butler J.
    J HIV Ther; 2006 Mar; 11(1):16-20. PubMed ID: 16706251
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S, Antunes OA, Fortunak JM.
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lack of autodisable syringe use and health care indicators are associated with high HIV prevalence: an international ecologic analysis.
    Deuchert E, Brody S.
    Ann Epidemiol; 2007 Mar; 17(3):199-207. PubMed ID: 17174567
    [Abstract] [Full Text] [Related]

  • 29. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET, Oelrichs RB.
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah R, Harries AD, Philips M, Arnould L, Sabapathy K, O'Brien DP, Ferreyra C, Balkan S.
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):387-91. PubMed ID: 20116814
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
    Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ.
    Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
    [Abstract] [Full Text] [Related]

  • 35. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K, van Griensven J, Huis in 't Veld D, Colebunders R.
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [Abstract] [Full Text] [Related]

  • 36. Antiretroviral drug development: the challenge of cost and access.
    Dunne M.
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography.
    Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A.
    Trop Med Int Health; 2010 Jun; 15 Suppl 1():16-33. PubMed ID: 20586957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.